Danaher CEO Comments on Outlook

Tue Jan 8, 2013 8:00pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link below:


Washington, D.C., January 8, 2013 - Danaher Corporation (NYSE:DHR) announced that its President
and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's
performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr.
Culp will communicate that the Company's fourth quarter 2012 diluted net earnings per share is
anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher
than expected core revenue growth in the quarter.

Mr. Culp stated: "We are pleased by the strong finish to the year from both a revenue and earnings
perspective, which was broad-based across most of our businesses."

As previously announced, the company will hold its quarterly earnings conference call for the
fourth quarter and year-end 2012 on Tuesday, January 29, 2013 at 8:00 a.m. EST.

* * *


Danaher is a science and technology leader that designs, manufactures, and markets innovative
products and services to professional, medical, industrial, and commercial customers.  Our premier
brands are among the most highly recognized in each of the markets we serve.  The Danaher Business
System provides a foundation to our 59,000 associates around the world, serving customers in more
than 125 countries.  In 2011, we generated $16.1 billion of revenue.  For more information please
visit our website: www.danaher.com http://www.danaher.com/ .


Statements in this release that are not strictly historical, including the statements regarding
the Company's anticipated diluted net earnings per share and core revenue growth for the fourth
quarter 2012 and any other statements regarding events or developments that we believe or
anticipate will or may occur in the future, are "forward-looking" statements within the meaning of
the federal securities laws.  There are a number of important factors that could cause actual
results, developments and business decisions to differ materially from those suggested or
indicated by such forward-looking statements and you should not place undue reliance on any such
forward-looking statements. These factors include, among other things, deterioration of or
instability in the economy and financial markets, the impact of our restructuring activities on
our ability to grow, contractions or growth rates and cyclicality of markets we serve,
competition, our ability to develop and successfully market new products and technologies and
expand into new markets, the potential for improper conduct by our employees, agents or business
partners, our ability to successfully identify, consummate and integrate appropriate acquisitions
(including our ability to effectively integrate the Beckman Coulter acquisition and realize the
anticipated benefits therefrom), contingent liabilities relating to acquisitions (including our
acquisition of Beckman Coulter) and divestures, our compliance with applicable laws and
regulations (including regulations relating to medical devices and the healthcare industry) and
changes in applicable laws and regulations, our ability to effectively address cost reduction and
other changes in the healthcare industry, risks relating to potential impairment of goodwill and
other long-lived assets, currency exchange rates, tax audits and changes in our tax rate and
income tax liabilities, litigation and other contingent liabilities including intellectual
property and environmental matters, risks relating to product defects and recalls, the impact of
our debt obligations on our operations, our relationships with and the performance of our channel
partners, commodity costs and surcharges, our ability to adjust purchases and  manufacturing
capacity to reflect market conditions, labor matters,  international economic, political, legal
and business factors, risks relating to man-made and natural disasters, pension plan costs and our
non-controlling interest in the Apex joint venture.  Additional information regarding the factors
that may cause actual results to differ materially from these forward-looking statements is
available in our SEC filings, including our 2011 Annual Report on Form 10-K and Quarterly Report
on Form 10-Q for the third quarter of 2012. These forward-looking statements speak only as of the
date of this release and the Company does not assume any obligation to update or revise any
forward-looking statement, whether as a result of new information, future events and developments
or otherwise.


Please contact:

Matt McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, NW
Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Danaher Corporation via Thomson Reuters ONE


Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.